Palantir tops estimates, boosts fourth-quarter guidance on AI adoption

Palantir tops estimates, boosts fourth-quarter guidance on AI adoption


Alex Karp, chief executive officer of Palantir Technologies Inc., speaks during the AIPCon conference in Palo Alto, California, US, on March 13, 2025.

David Paul Morris | Bloomberg | Getty Images

Palantir reported quarterly results that topped analysts’ estimates and issued better-than-expected guidance for the fourth quarter, attributing much of its strength to artificial intelligence. The stock rose about 3% in extended trading.

Here’s how the company did compared to LSEG estimates

Earnings per share: 21 cents vs. 17 cents expected

Revenues: $1.18 billion vs. $1.09 billion expected

Palantir, which builds analytics tools for large companies and government agencies, said it expects revenue of about $1.33 billion for the current period, exceeding the $1.19 billion expected by analysts, according to LSEG.

The optimistic guidance comes even as the government shutdown stretches into its second calendar month, and potentially threatens some key contracts. Revenue in Palantir’s government business grew 52% in the quarter from a year ago to $486 million.

Government sales, particularly from military agencies, have been central to Palantir’s ongoing ascent. Over the years, Palantir has steadily beat out major legacy government contractors, and recently landed a deal worth up to $10 billion contract with the U.S. Army.

Palantir has also faced criticism over how its tools are being used by government agencies, including U.S. Immigration and Customs Enforcement.

Total revenue in the quarter jumped 63% from $725.5 million a year ago, exceeding $1 billion for the second straight quarter. Net income more than tripled to $475.6 million, or 18 cents per share, from $143.5 million, or 6 cents per share, a year earlier.

For the full year, Palantir now expects about $4.4 billion in sales, topping the $4.17 billion forecast by Wall Street. The company also bumped up its full-year free cash flow outlook to between $1.9 billion and $2.1 billion.

Palantir’s commercial business more than doubled to $397 million. Total contract value for commercial deals closed more than quadrupled to $1.31 billion. Over the last few weeks, the company has announced new partnerships with Snowflake, Lumen and Nvidia.

Retail investors have helped drive Palantir’s skyrocketing stock price to new heights. The shares have surged more than 170% this year, lifting the company’s market cap past $490 billion and cementing the company among the most valuable technology names in the world.

Analysts have raised concerns about the stock, which trades at an extreme multiple relative to technology behemoths with far more revenue. In a letter to shareholders, CEO Alex Karp called out the “detractors” who have been “left in a kind of deranged and self-destructive befuddlement.”

“The reality is that Palantir has made it possible for retail investors to achieve rates of return previously limited to the most successful venture capitalists in Palo Alto,” he wrote. “And we have done so through authentic and substantive growth.”

WATCH: D.A. Davidson’s Luria on Palantir

Palantir is the best software company and it's not even close, says D.A. Davidson's Gil Luria



Source

Alex Karp blasts ‘Big Short’ investor Michael Burry as ‘bats— crazy’ for bets against Palantir, Nvidia
World

Alex Karp blasts ‘Big Short’ investor Michael Burry as ‘bats— crazy’ for bets against Palantir, Nvidia

Palantir CEO Alex Karp ranted against short sellers, calling out specifically Michael Burry after a filing revealed the investor of “The Big Short” fame had bets against the artificial intelligence software company, as well as Nvidia, at the end of the last quarter. “The two companies he’s shorting are the ones making all the money, […]

Read More
Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer
World

Metsera says Novo Nordisk’s new bid for obesity drugmaker is ‘superior’ to revised Pfizer offer

The logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy is seen outside theri building as the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Metsera on Tuesday said Novo Nordisk‘s new […]

Read More
Post Hindenburg, Adani Enterprises plans to raise .8 billion from rights issue
World

Post Hindenburg, Adani Enterprises plans to raise $2.8 billion from rights issue

Indian billionaire Gautam Adani attends the 51st Gems and Jewellery Awards in Jaipur, India, November 30, 2024.  Stringer | Reuters Adani Enterprises on Tuesday announced plans to raise 250 billion rupees ($2.8 billion) through a rights issue of shares as it seeks to move on from the controversy that erupted the last time it announced […]

Read More